Dow Jones

42 544,22

-0,07%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

GLTO

Galecto (GLTO)

Galecto Inc

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:GLTO

Date	Heure	Source	Titre	Symbole	Société
07/11/2024	21h07	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:GLTO	Galecto Inc
07/11/2024	20h55	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:GLTO	Galecto Inc
01/11/2024	13h00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:GLTO	Galecto Inc
15/10/2024	15h15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GLTO	Galecto Inc
11/10/2024	23h00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GLTO	Galecto Inc
11/10/2024	22h30	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:GLTO	Galecto Inc
08/03/2024	22h29	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:GLTO	Galecto Inc
08/03/2024	22h00	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:GLTO	Galecto Inc
09/02/2024	21h06	Edgar (US Regulatory)	Form SCHEDULE 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:GLTO	Galecto Inc
03/10/2023	17h29	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:GLTO	Galecto Inc
15/06/2023	22h01	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:GLTO	Galecto Inc
15/06/2023	22h01	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:GLTO	Galecto Inc
28/04/2023	15h02	Edgar (US Regulatory)	Annual Report to Security Holders (ars)	NASDAQ:GLTO	Galecto Inc
28/04/2023	13h06	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:GLTO	Galecto Inc
28/04/2023	12h20	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:GLTO	Galecto Inc
05/04/2023	23h29	Edgar (US Regulatory)	Report of Proposed Sale of Securities (144)	NASDAQ:GLTO	Galecto Inc
10/11/2022	05h35	TipRanks	SVB Securities Remains a Buy on Galecto (GLTO)	NASDAQ:GLTO	Galecto Inc
02/11/2022	05h45	TipRanks	SVB Securities Reaffirms Their Buy Rating on Galecto (GLTO)	NASDAQ:GLTO	Galecto Inc
30/09/2022	22h53	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:GLTO	Galecto Inc
04/08/2022	15h25	TipRanks	Analysts Have Conflicting Sentiments on These Healthcare Companies: Anika Therapeutics (ANIK) and Galecto (GLTO)	NASDAQ:GLTO	Galecto Inc
10/05/2022	11h02	TipRanks	Analysts Have Conflicting Sentiments on These Healthcare Companies: Thermo Fisher (TMO), Galecto (GLTO) and Eledon Pharmaceuticals (ELDN)	NASDAQ:GLTO	Galecto Inc
28/04/2022	22h43	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:GLTO	Galecto Inc
18/02/2022	23h02	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:GLTO	Galecto Inc
17/02/2022	22h37	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:GLTO	Galecto Inc
17/02/2022	22h29	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:GLTO	Galecto Inc
14/02/2022	21h15	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:GLTO	Galecto Inc
05/01/2022	23h02	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:GLTO	Galecto Inc
15/11/2021	12h32	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:GLTO	Galecto Inc
04/11/2021	22h02	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:GLTO	Galecto Inc
12/02/2021	22h01	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:GLTO	Galecto Inc